Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 551

The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.

Significance of long chain polyunsaturated fatty acids in human health

Open access
Zárate, Rafael, el Jaber‐Vazdekis, Nabil, Tejera, Noemi, Pérez, José A., Rodríguez, Covadonga·2017·Clinical and Translational Medicine

Abstract

In the last decades, the development of new technologies applied to lipidomics has revitalized the analysis of lipid profile alterations and the understanding of the underlying molecular mechanisms of lipid metabolism, together with their involvement in the occurrence of human disease. Of particular interest is the study of omega‐3 and omega‐6 long chain polyunsaturated fatty acids (LC‐PUFAs), notably EPA (eicosapentaenoic acid, 20:5n‐3), DHA (docosahexaenoic acid, 22:6n‐3), and ARA (arachidonic acid, 20:4n‐6), and their transformation into bioactive lipid mediators. In this sense, new families of PUFA‐derived lipid mediators, including resolvins derived from EPA and DHA, and protectins and maresins derived from DHA, are being increasingly investigated because of their active role in the “return to homeostasis” process and resolution of inflammation. Recent findings reviewed in the present study highlight that the omega‐6 fatty acid ARA appears increased, and omega‐3 EPA and DHA decreased in most cancer tissues compared to normal ones, and that increments in omega‐3 LC‐PUFAs consumption and an omega‐6/omega‐3 ratio of 2–4:1, are associated with a reduced risk of breast, prostate, colon and renal cancers. Along with their lipid‐lowering properties, omega‐3 LC‐PUFAs also exert cardioprotective functions, such as reducing platelet aggregation and inflammation, and controlling the presence of DHA in our body, especially in our liver and brain, which is crucial for optimal brain functionality. Considering that DHA is the principal omega‐3 FA in cortical gray matter, the importance of DHA intake and its derived lipid mediators have been recently reported in patients with major depressive and bipolar disorders, Alzheimer disease, Parkinson's disease, and amyotrophic lateral sclerosis. The present study reviews the relationships between major diseases occurring today in the Western world and LC‐PUFAs. More specifically this review focuses on the dietary omega‐3 LC‐PUFAs and the omega‐6/omega‐3 balance, in a wide range of inflammation disorders, including autoimmune diseases. This review suggests that the current recommendations of consumption and/or supplementation of omega‐3 FAs are specific to particular groups of age and physiological status, and still need more fine tuning for overall human health and well being.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40169-017-0153-6

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 151 references

Cited by

See all 551

Metadata

Authors
Zárate, R., el Jaber‐Vazdekis, N., Tejera, N., Pérez, J. A., & Rodríguez, C.
Venue
Clinical and Translational Medicine
Publisher
Wiley
Published
2017-07-27
Volume
6
Issue
1
Pages
25-25
ISSN
2001-1326 (ISSN-L)
OpenAlex
W2739710852
Cited by
551
References
151
FWCI
32.00
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Significance of long chain polyunsaturated fatty acids in human health. https://app.cochat.ai/papers/10.1186/s40169-017-0153-6
The paper
Zárate, R., el Jaber‐Vazdekis, N., Tejera, N., Pérez, J. A., & Rodríguez, C. (2017). Significance of long chain polyunsaturated fatty acids in human health. Clinical and Translational Medicine. https://doi.org/10.1186/s40169-017-0153-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.